Live from the NIH registry
Studies recruiting near Killeen right now
Top 25 of 105 recruiting studies, sorted by proximity — each links to its official registry page
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Heart Failure (HF)
N/A
Interventional 420 participants sought
Baylor Scott & White Research Institute — Temple, Texas (22.9 mi)
· Sponsor: Aventusoft, LLC.
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: National Cancer Institute (NCI)
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
Acute Myeloid Leukemia (AML)
Phase 2
Interventional 108 participants sought
Baylor Scott & White Research Institute — Temple, Texas (22.9 mi)
· Sponsor: Bio-Path Holdings, Inc.
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
MD Anderson Cancer center — Woodland, Texas (14.7 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center
Traumatic Injury, PTSD
N/A
Interventional 300 participants sought
Baylor Scott & White Medical Center - Temple — Temple, Texas (22.9 mi)
· Sponsor: Baylor Research Institute
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Gastrointestinal Cancer
Phase 1, Phase 2
Interventional 180 participants sought
Scott & White Medical Center-Temple ( Site 1224) — Temple, Texas (22.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
Phase 3
Interventional 4,800 participants sought
Research Site — Temple, Texas (22.9 mi)
· Sponsor: AstraZeneca
Alleviant ALLAY-HFrEF Study
Heart Failure
N/A
Interventional 350 participants sought
Baylor Scott & White - Temple — Temple, Texas (22.9 mi)
· Sponsor: Alleviant Medical, Inc.
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Cancer Harboring BRAF Alterations, HGG
Phase 2
Interventional 254 participants sought
Baylor Scott & White Medical Center — Temple, Texas (22.9 mi)
· Sponsor: Fore Biotherapeutics
Multisite Advancement of Research on Chronic Posttraumatic Headache
Posttraumatic Headache
N/A
Interventional 525 participants sought
Carl R. Darnall Army Medical Center (Fort Cavazos) — Killeen, Texas (2.9 mi)
· Sponsor: The University of Texas Health Science Center at San Antonio
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: National Cancer Institute (NCI)
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Chronic Kidney Disease(CKD), Type 2 DM
N/A
Interventional 750 participants sought
Baylor Scott & White — Temple, Texas (22.9 mi)
· Sponsor: Duke University
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
Stroke, PFO - Patent Foramen Ovale
N/A
Interventional 636 participants sought
Baylor Scott & White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: W.L.Gore & Associates
Acceptance and Commitment Therapy Integrated Vestibular Rehabilitation (ACTIVE) RCT
Concussion, Mild, Mild Traumatic Brain Injury (mTBI)
N/A
Interventional 250 participants sought
Intrepid Spirit Center, Carl R. Darnall Army Medical Center — Fort Hood, Texas (12.5 mi)
· Sponsor: University of Pittsburgh
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Baylor Scott and White Health — Temple, Texas (22.9 mi)
· Sponsor: Boehringer Ingelheim
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: SWOG Cancer Research Network
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Baylor Scott and White Medical Center — Temple, Texas (22.9 mi)
· Sponsor: Relay Therapeutics, Inc.
Non-Trauma Intervention to Treat PTSD for Veterans and Service Members Suffering From a TBI
PTSD, Post Traumatic Stress Disorder
N/A
Interventional 30 participants sought
Carl R Darnall Army Medical Center — Fort Hood, Texas (12.5 mi)
· Sponsor: The University of Texas Health Science Center at San Antonio
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Acute Myeloid Leukemia
Phase 3
Interventional 1,186 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: Children's Oncology Group
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Phase 2
Interventional 372 participants sought
Baylor Scott & White Medical Center - Temple — Temple, Texas (22.9 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Behavioral Insomnia Treatment in Mild Traumatic Brain Injury
Insomnia, Mild Traumatic Brain Injury
N/A
Interventional 160 participants sought
Carl R. Darnall Army Medical Center — Fort Cavazos, Texas (4.9 mi)
· Sponsor: The University of Texas Health Science Center at San Antonio
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Heart Failure, Heart Diseases
N/A
Interventional 850 participants sought
Scott & White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: Abbott Medical Devices
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8
Phase 2
Interventional 111 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: National Cancer Institute (NCI)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8
Phase 2
Interventional 2,900 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluation of a Group-based, Skills Training for Increasing Mental Toughness
Resilience, Mental Toughness
N/A
Interventional 2,400 participants sought
Fort Hood — Killeen, Texas (2.9 mi)
· Sponsor: Uniformed Services University of the Health Sciences